These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7279512)

  • 21. [Determination of carbocromen in the air of a work area].
    Bake MIa
    Gig Tr Prof Zabol; 1982 Apr; (4):53-6. PubMed ID: 7084777
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of carbocromen on the ST segment of the epicardial electrocardiogram in a model of intermitting myocardial ischemia (author's transl)].
    Sirbulescu R; Scholtholt J; Nitz RE; Kunath B
    Arzneimittelforschung; 1976 Feb; 26(2):204-8. PubMed ID: 820356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on inhibition of platelet aggregation by carbocromen (author's transl)].
    Resag K; Melzer G; Nitz RE
    Arzneimittelforschung; 1976 Feb; 26(2):209-13. PubMed ID: 947200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet aggregation and adhesiveness as well as blood lipids level in dogs treated with di-(1-isoquinolinyl)-di-(pyridyl-2')-butane and carbocromen.
    Woyke M; Cwajda H; Wójcicki J
    Pol J Pharmacol Pharm; 1978; 30(1):77-81. PubMed ID: 643741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of ditrimine and carbocromen on the concentration of adenylic nucleotides in the myocardium of rabbits with experimental coronary spasm].
    Chekman IS; Puzen'kina NN
    Farmakol Toksikol; 1977; 40(2):166-8. PubMed ID: 67053
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of carbocromen and of other coronary dilator agents on the blood flow of a myocardial ischemic area].
    Faucon G; Ollagnier M; de Claviere M; Kofman J; Evreux JC
    Therapie; 1975; 30(2):185-95. PubMed ID: 1162641
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitamin D-induced myocardial lesions and the protection by carbocromen.
    Takeo S; Schraven E; Keil M; Nitz RE
    Arzneimittelforschung; 1982; 32(11):1412-7. PubMed ID: 6891244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quantitative EEG analysis of the effects of carbocromen, pentetrazole, beta-methyldigoxin, and strophantin-K in normal human volunteers (author's transl)].
    Maxion H; Klein G; Wolf B; Zöllner U
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):286-90. PubMed ID: 616928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bioavailability of a delayed-action form of a coronary-dilator agent].
    Sestini G; Zagaria F
    Farmaco Prat; 1976 Feb; 31(2):102-10. PubMed ID: 1253953
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical study of carbocromen (chromonar), new coronary vasodilator].
    Mallion JM; Denis B; Rival M
    J Med Lyon; 1969 Mar; 50(160):411-3. PubMed ID: 5784251
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical trial of Cardiocap in coronary insufficiency].
    Baronti G; Del Corso P; Romboli L
    Minerva Cardioangiol; 1974 May; 22(5):344-55. PubMed ID: 4619188
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interaction of coronary-active compounds and anti-inflammatory drugs on the coronary vascular system (author's transl)].
    Jacobi H; Jentzsch KR; Lüdtke W; Schwarz H
    Arzneimittelforschung; 1981; 31(10):1704-10. PubMed ID: 7198446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spectrophotometric determination of intensain].
    Muzhanovskii EB; Beikin SG; Sedov AI
    Farm Zh; 1978; (1):67-70. PubMed ID: 631305
    [No Abstract]   [Full Text] [Related]  

  • 34. [Letter: Anti-anginous effect of intensain].
    Dtsch Med Wochenschr; 1976 Mar; 101(11):429. PubMed ID: 1253708
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bleeding time and cardioactive drugs. Effects of dipyridamole and carbochromen].
    Rubegni M; De Mauro G; Provvedi D; Bandinelli C; Bellini PG
    Boll Soc Ital Cardiol; 1975; 20(8):875-80. PubMed ID: 1233046
    [No Abstract]   [Full Text] [Related]  

  • 36. The action of AD6 on experimental arrhythmias and on action potentials of cardiac fibers.
    Bertolino M; Prosdocimi M; Aporti F; Finesso M; Gorio A
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):66-78. PubMed ID: 3753098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemodynamic effects of carbochromene].
    Dabizzi RP; Franchi F; Malfanti PL; Padeletti L
    Boll Soc Ital Cardiol; 1976; 21(2):349-55. PubMed ID: 1031000
    [No Abstract]   [Full Text] [Related]  

  • 38. [Further progress in the treatment of the coronary disease].
    Pillen D
    Med Welt; 1976 Mar; 27(12):581-5. PubMed ID: 772355
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative effectiveness of phenicaberan and carbochromen in ischemic heart disease].
    Todosienko LA
    Vrach Delo; 1980 Aug; (8):51-5. PubMed ID: 7415129
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental studies on the toxicity of Ferula communis in the rat.
    Aragno M; Tagliapietra S; Nano GM; Ugazio G
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):399-402. PubMed ID: 3363223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.